Par Pharmaceutical to Acquire Second Generics Company of 2011

By Heather Cartwright

Pharma Deals Review: Vol 2011 Issue 9 (Table of Contents)

Published: 1 Sep-2011

DOI: 10.3833/pdr.v2011.i9.1528     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Par Pharmaceutical has agreed to buy privately held Anchen Pharmaceuticals for US$410 M in order to expand its generic drugs portfolio...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details